Page last updated: 2024-11-07

metaraminol and Hemiplegia

metaraminol has been researched along with Hemiplegia in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Hemiplegia: Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farhat, SM1
Schneider, RC1
Wernick, S1
Sugar, O1

Other Studies

2 other studies available for metaraminol and Hemiplegia

ArticleYear
Observations on the effect of systemic blood pressure on intracranial circulation in patients with cerebrovascular insufficiency.
    Journal of neurosurgery, 1967, Volume: 27, Issue:5

    Topics: Acute Disease; Adult; Blood Pressure; Carotid Artery Diseases; Cerebrovascular Circulation; Cerebrov

1967
Treatment of postangiographic hemiplegia with vasopressors. Case report.
    Journal of neurosurgery, 1974, Volume: 41, Issue:6

    Topics: Blood Pressure; Carotid Arteries; Cerebral Angiography; Diatrizoate; Hemiplegia; Humans; Male; Metar

1974